Please use this identifier to cite or link to this item:
|Title:||Interplay between nitric oxide and vasoactive intestinal polypeptide in inducing fluid secretion in rat jejunum||Authors:||Mourad, Fadi H.
Bou Rached, Nadine A.
Khoury, Carmen Ibrahim
Nassar, Camille F
|Affiliations:||Faculty of Medicine||Issue Date:||2003||Part of:||Journal of physiology||Volume:||550||Issue:||3||Start page:||863||End page:||871||Abstract:||
Nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) interact in the regulation of neuromuscular function in the gut. They are also potent intestinal secretogogues that coexist in the enteric nervous system. The aims of this study were: (1) to investigate the interaction between NO and VIP in inducing fluid secretion in the rat jejunum, and (2) to determine whether the NO effect on intestinal fluid movement is neurally mediated. The single pass perfusion technique was used to study fluid movement in a 25 cm segment of rat jejunum in vivo. A solution containing 20 mml-arginine, a NO precursor, was perfused into the segment. The effect of the NO synthase inhibitors (l-NAME and l-nitroindazole (l-NI)) and the VIP antagonist ([4Cl-D-Phe6,Leu17]VIP (VIPa)) on l-arginine-induced changes in fluid movement, expressed as μl min−1 (g dry intestinal weight)−1, was determined. In addition, the effect of neuronal blockade by tetrodotoxin (TTX) and ablation of the myenteric plexus by benzalkonium chloride (BAC) was studied. In parallel groups of rats, the effect of l-NAME and l-NI on VIP-induced intestinal fluid secretion was also examined. Basal fluid absorption in control rats was (median (interquartile range)) 65 (45–78). l-Arginine induced a significant fluid secretion (−14 (−20 to −5); P < 0.01). This effect was reversed completely by l-NAME (60 (36–65); P < 0.01) and l-NI (46 (39–75); P < 0.01) and partially by VIPa (37 (14–47); P < 0.01). TTX and BAC partially inhibited the effect of l-arginine (22 (15–32) and 15 (10–26), respectively; P < 0.05). The effect of VIP on fluid movement (−23 (−26 to −14)) was partially reversed by l-NAME (24 (8.4–35.5); P < 0.01) and l-NI (29 (4–44); P < 0.01). The inhibition of VIP or NO synthase prevented l-arginine- and VIP-induced intestinal fluid secretion through a neural mechanism. The data suggest that NO enhances the release of VIP from nerve terminals and vice versa. Subsequently, each potentiates the other's effect in inducing intestinal fluid secretion.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/2166||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Faculty of Medicine|
Show full item record
checked on Dec 5, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.